Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Celin is an over-the-counter oral vitamin C supplement brand containing ascorbic acid or sodium ascorbate, used for the prevention and treatment of vitamin C deficiency and related conditions such as scurvy, impaired wound healing, and increased requirements during growth, pregnancy, lactation, infection, or recovery from severe illness. Ascorbic acid acts as a water‑soluble antioxidant and electron donor that functions as a cofactor for multiple enzymes involved in collagen synthesis, catecholamine and carnitine biosynthesis, steroid and tyrosine hydroxylation, folate metabolism, and iron absorption, thereby supporting connective tissue integrity, immune function, and redox homeostasis.[2][3][6][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Celin.